SCHEMBL695561

SCHEMBL695561

C=CCNN(CCCCC)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.45
ZDHHC20 Q5W0Z9 2/20 0.36
ZDHHC2 Q9UIJ5 2/20 0.36
ALDH1A1 P00352 1/20 0.35
TSHR P16473 3/20 0.34
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
SOAT1 P35610 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
CNR1 P21554 1/20 0.32
ICMT O60725 1/20 0.31
ALB P02768 1/20 0.31
KDM5A P29375 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694140 0.83 ALDH1A1 (0.38) FAAHZDHHC20ZDHHC2ALDH1A1TSHR
SCHEMBL7746903 0.76 FAAH (0.40) FAAHZDHHC20ZDHHC2ALDH1A1TSHR
SCHEMBL16266175 0.76 ALDH1A1 (0.35) ALDH1A1TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL1838870 0.74 KDM5A (0.34) FAAHMEN1TP53CYP1A2CYP3A4
SCHEMBL9423866 0.73 FAAH (0.42) FAAHZDHHC20ZDHHC2ALDH1A1TSHR
SCHEMBL29333 0.71 ZDHHC20 (0.45) FAAHZDHHC20ZDHHC2ALDH1A1TSHR
SCHEMBL8969203 0.71 ZDHHC20 (0.44) FAAHZDHHC20ZDHHC2TSHRMEN1
SCHEMBL11085445 0.70 ZDHHC20 (0.47) FAAHZDHHC20ZDHHC2ALDH1A1TSHR
SCHEMBL28001802 0.69 ZDHHC20 (0.46) FAAHZDHHC20ZDHHC2TSHRMEN1
SCHEMBL27464906 0.69 CA1 (0.35) FAAHMEN1TP53CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1975158-B9 NOVEL PYRROLE DERIVATIVES WITH HISTONE DEACETYLASE INHIBITOR ACTIVITY UNIV PAIS VASCO (ES) 2012-02-29 EP disclosed
EP-1975158-B1 NOVEL PYRROLE DERIVATIVES WITH HISTONE DEACETYLASE INHIBITOR ACTIVITY UNIV PAIS VASCO (ES) 2011-07-13 EP disclosed
US-7638550-B2 new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to their inhibitory activity on certain histone deacetylases. Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU) Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III (CNIO) (ES) 2009-12-29 US disclosed
US-20080262073-A1 Pyrrolic Derivatives with Histone Deacetylase Inhibitory Activity FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III (CNIO) (ES) 2008-10-23 US disclosed
EP-1975158-A1 NOVEL PYRROLE DERIVATIVES WITH HISTONE DEACETYLASE INHIBITOR ACTIVITY UNIVERSIDAD DEL PAIS VASCO-EUSKAL HERRIKO UNIBERSITATEA (ES) 2008-10-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262073-A1 Pyrrolic Derivatives with Histone Deacetylase Inhibitory Activity HDAC1, HDAC11, HDAC5 FAAH 2609/4885ZDHHC20 848/4885ZDHHC2 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.